INTCO MEDICAL(SZ:300677) Xin Lang Cai Jing·2025-10-20 12:12Core Viewpoint - The company plans to invest $70 million in the Warburg Pincus Global Growth 15, L.P. partnership, which aims to raise a total of $17 billion [1] Group 1: Investment Details - The investment will be made by the company's wholly-owned subsidiary, Yingke Medical International (Hong Kong) Limited [1] - The transaction is classified as a related party transaction but does not exceed 5% of the company's latest audited net assets, thus not requiring shareholder approval [1] Group 2: Strategic Objectives - The investment aims to optimize the company's investment structure and enhance its global strategic layout [1] - The company seeks to leverage a specialized investment management team to improve its revenue levels and long-term strategic development [1]